Tyler Division, Eastern District of Texas
Dec. 19
Plaintiff Stragent is a Texas limited liability company with its principal place of business in Longview.
Stragent claims to own the rights to U.S. Patent No. 7,424,431 issued Sept. 9, 2008, for a System, Method and Computer Program Product for Adding Voice Activation and Voice Control to a Media Player.
The plaintiff alleges that Pioneer has been and is now infringing the '431 Patent by making and selling audio products including the Pioneer AVIC-F900BT, 700BT and F7010BT.
Stragent claims it has suffered monetary damages and should be compensated in an amount no less than a reasonable royalty.
The plaintiff is seeking damages, costs, expenses, interest and any and all relief to which it may be entitled.
Eric Albritton of the Albritton Law Firm and Thomas John Ward Jr. of Ward & Smith Law Firm, both of Longview are representing the plaintiff.
The case has been assigned to U.S. District Judge Leonard E. Davis.
Case No. 6:08-cv-493-LED
Plaintiff Saxon Innovations LLC is a Texas corporation with its corporate offices in Tyler.
Saxon claims to own the rights to three U.S. patents dealing with technology for cell phones, handheld computers and other wireless communications devices.
The patents-in-suit are:
Saxon alleges defendants Nokia, Palm, Research In Motion, High Tech Computer and Panasonic are infringing the patents-in-suit.
The plaintiff is seeking a preliminary and permanent injunction, an award of damages sufficient to compensate for the infringements, interest, expenses, attorneys' fees and other just and proper relief.
T. John Ward Jr. of Ward & Smith Law Firm in Longview is representing the plaintiff, with attorneys from Pepper Hamilton LLP of Boston, Mass., of counsel.
The case has been assigned to U.S. District Judge Leonard E. Davis.
Case No. 6:08-cv-494-LED
Dec. 22
Plaintiff Softrend claims to be the owner of U.S. Patent No. 5,640,788 issued June 24, 1997, for a Noise Making Sole for Footware.
Softrend alleges defendants Mooshu Trainers Inc., Squeaker Sneakers LLC and New Century Business LLC doing business as China Direct Store are infringing the '788 Patent through sales of noise-making shoes.
The plaintiff also alleges that the infringement has been willful and deliberate.
Softrend seeks injunctive relief, interest, attorneys' fees and other just and proper relief.
Dariush Keyhani of New York, N.Y., is lead attorney for the plaintiff, along with Andy Tindel of the Provost Umphrey office in Tyler.
The case has been assigned to U.S. District Judge Leonard E. Davis.
Case No. 6:08-cv-495-LED
Plaintiff PACid is a Texas limited liability company with its principal place of business in Tyler.
According to the complaint, PACid is the owner by assignment of U.S. Patent No. 5,963,646 issued Oct. 5, 1999, for a Secure Deterministic Encryption Key Generator System and Method.
PACid also claims to be the owner of U.S. Patent No. 6,049,612 issued April 11, 2000, for a File Encryption Method and System.
The suit alleges defendant companies 2Wire, 3Com, Acer, Brother, Canon, NEC, Nokia, Panasonic, Sharp and Thomson infringe the '646 and '612 Patents.
PACid claims the defendants infringe its patents through products that employ methods for generating pseudo-random, symmetric inscription keys used to encrypt and decrypt data transmitted over wireless networks.
The plaintiff is seeking injunctive relief, compensatory and enhanced damages, costs, expenses, interest, attorneys' fees and other relief to which it may be entitled.
Andrew Spangler of Spangler Law PC in Longview is lead attorney for the plaintiff.
The case has been assigned to U.S. District Judge Leonard E. Davis.
Case No. 6:08-cv-498-LED
Dec. 24
Plaintiff Bayer claims to own the rights to U.S. Patent No. 5,654,407 issued Aug. 5, 1997, for Human Anti-TNF Antibodies.
Bayer alleges that defendants Abbott Laboratories, Abbott Bioresearch Center Inc. and Abbott Biotechnology Ltd. infringe the '407 Patent. The defendants make, use or sell human monoclonal antibodies that bind specifically to human tumor necrosis factor alpha, known generally under the trade name Humira and the nonproprietary name adalimumab for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and plaque psoriasis.
"Upon information and belief, defendants' manufacture, use, offer for sale and/or sale of Humira infringes, induces the infringement and/or contributes to the infringement of one or more claims of the '407 Patent," the complaint states.
Bayer also alleges the infringement has been willful and deliberate and in disregard of Bayer's rights under the '407 Patent.
The plaintiff is seeking compensatory and treble damages, interest, costs, attorneys' fees and other just and proper relief.
T. John Ward Jr. of the Ward & Smith Law Firm in Longview is lead attorney for the plaintiff, with Eric Albritton of Albritton Law Firm in Longview, Bartlit Beck Herman Palenchar & Scott LLP of Chicago and Ropes & Gray LLP of New York.
The case has been assigned to U.S. District Judge Leonard E. Davis.
Case No. 6:08-cv-507-LED